Business Wire

Backlight to Showcase Product Line Innovations Across Creative and Streaming Workflows at IBC 2023

7.9.2023 18:50:00 EEST | Business Wire | Press release

Share

Global media and entertainment technology company Backlight announced that it is returning to the International Broadcasting Convention (IBC) this month with many new product updates and integrations to share with the industry. Backlight will be at booth 1.D09 to showcase innovative solutions that improve the video content lifecycle for broadcasters, content creators, publishers and distributors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230907741048/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Global media and entertainment technology company Backlight will showcase its feature-rich solutions that reduce pain points across the video lifecycle for more streamlined production and monetization at the 2023 International Broadcasting Convention (IBC). (Graphic: Business Wire)

Request a meeting with Backlight at IBC here.

Backlight Product Updates and Integrations

Backlight’s feature-rich solutions allow broadcasters and rights owners to create more content, distribute everywhere, unlock new revenue streams, and manage media and creative projects in the cloud intelligently and economically. The latest updates to its products to reduce pain points across the video lifecycle for more streamlined production and monetization include:

  • Wildmoka Live Studio: Backlight’s new digital-first live production platform. Backlight will demonstrate how Live Studio’s single interface makes it easy to tailor an existing live stream, or create a new one, from multiple live sources, clips, graphics and images, while preserving brand consistency with pre-configured production rooms and templated destinations. With the browser-based Live Studio, customers quickly generate platform-specific, low-latency content experiences and engage broader audiences through simultaneous distribution to any digital destination.
  • AI-assisted inventory creation within Zype Playout. Backlight’s ability to detect ad opportunities using machine learning is combined with low latency ad routing, device targeting, and a custom approach to ad macros in the newest version of Zype Playout. Customers have seen 516% increases in ad inventory, 15% increases in fill rate and 44% improvements in ad rendering when compared to leading playout providers.
  • Asset management, cloud production and content distribution – simplified. Backlight will showcase how easy it is to pull assets from any storage managed by iconik into Wildmoka’s live production environment for hyperdistribution as well as workflows for metadata-intelligent live-to-archive.
    • Add media management, review and collaboration to live media management workflows and scale up in the cloud for key events.
    • Push clips or archived content from Wildmoka to iconik for long-term storage, quick discovery, and reutilization in marketing initiatives – all in a browser.
  • New features and integrations for iconik, ftrack and cineSync increase creative workflow speed, flexibility and control.
    • iconik’s Favoriting functionality allows quicker retrieval of key assets, and updates to Collections now provide detailed insights into their sizes and creation history to empower better storage decision-making and resource allocation.
    • iconik demos will include a forthcoming integration with Apple's Final Cut Pro X that empowers users to effortlessly import/export iconik media directly into their FCPX editing environment and an updated integration with the powerful media review and approval solution cineSync.
    • cineSync expands format and standards support with OTIOZ playback, USD support and new ways to manage colors and notes in cineSync 5
    • ftrack Studio offers next-level precision for creative reviews by adding Wacom and stylus support and increased control for production tracking with new task scheduling and notification options.

Backlight’s Leaders to Share Insights on Monetizing Content and Remote Production

Leaders from Backlight will participate in two thought leadership forums at IBC—the SVG Sport Production Summit and the DPP Espresso Summit:

SVG Europe Sport Production Summit | Thursday, September 14, 2023 at 15:05 CET

  • Christophe Messa, Backlight’s director of Strategic Partners will join panelists from Tinkerlist, Spiideo, and Vislink for a discussion on Making and Monetizing Sports Content at the SVG Europe Sports Production Summit. Attendees will learn about best practices and new strategies that right owners are using to generate income for sports content, including on social media, OTT platforms and apps.

DPP Espresso Summit | Friday, September 15, 2023 at 0930 CET

  • At this breakfast briefing hosted by DPP, Backlight Chief Product Officer, Mike Szumlinski and other panelists will discuss hybrid working and the technology needed to support remote production more broadly.

Backlight is Shortlisted for Three Awards at IBC

  • The International Trade Association for the Broadcast & Media Industry (IABM) has shortlisted Backlight’s media management platform, iconik, for a BaM award in the Manage category. Iconik revolutionizes how organizations of all sizes manage, share and collaborate on digital assets.
  • Backlight’s Zype Apps Creator solution was shortlisted for an award by CSI Magazine in the Best VoD or content-on-demand solution category. Zype Apps Creator is Backlight’s turnkey solution for building streaming apps to deliver and monetize branded experiences across owned and operated and popular third-party platforms.
  • Backlight has been shortlisted for a Corporate Star award for Best Charity/CSR initiative for its collaboration with HUFO, a student-led film organization at Howard University that provides students with the resources they need to launch and leverage careers within the entertainment industry.

About Backlight

Backlight is a global media technology company that dramatically improves every stage of the video and entertainment content lifecycle, from creation through monetization. Backed by $200M in funding from PSG, Backlight has acquired six leading media software companies since launching in 2021. Video-forward organizations solve their mission-critical business and operational challenges by partnering with Backlight’s two divisions: Backlight Creative and Backlight Streaming. Backlight Creative provides award-winning software solutions for secure and efficient media management, production tracking and creative collaboration, including iconik, ftrack, Gem and Celtx. Backlight Streaming provides cloud-based OTT video streaming, content management, media production, hyperdistribution, and monetization software, including Zype and Wildmoka, to the world’s most innovative publishers and broadcasters. For more information visit backlight.co.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bubble Agency for Backlight | backlight@bubbleagency.com
Backlight | media@backlight.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio29.4.2026 14:42:00 EEST | Press release

Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista Pharmaceuticals, Inc.(“KalVista”) (Nasdaq: KALV), today announced that the companies have entered into a definitive agreement under which Chiesi will acquire KalVista (the “Transaction”). The Transaction was unanimously approved by both Chiesi’s and KalVista’s Boards of Directors and is expected to close in Q3 2026, subject to the satisfaction of customary closing conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429263104/en/ • Chiesi agreed to acquire KalVista Pharmaceuticals for $27.00 per share in cash, representing an equity consideration of approximately $1.9bn • Acquisition adds to Chiesi’s rare immunology portfolio the first oral, on-demand therapy for hereditary angioedema, strengthening Chiesi’s long-term commitment to people living with rare conditions • Transaction expected to close in

Pacific Defense Awarded U.S. Marine Corps Contract for Next Generation Electronic Warfare Prototype29.4.2026 14:00:00 EEST | Press release

Pacific Defense has been awarded a 12-month rapid prototyping contract by the U.S. Marine Corps Systems Command (MARCORSYSCOM), Program Manager for Tactical Communications and Electronic Warfare (PM TCE) to support next-generation electronic warfare (EW) capability evaluation. The effort will assess Modular Open Systems Approach (MOSA) Electronic Warfare (EW) mission systems and their potential in modernizing USMC capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429918712/en/ Pacific Defense's Next Generation Electronic Warfare System enables rapid integration of new hardware and software into a common chassis, accelerating capability insertion while reducing vendor lock and lifecycle costs. Under the contract, Pacific Defense will deliver SOSA/CMOSS-aligned mission systems to enable vehicle-based experimentation by U.S. Marines. The Next Generation EW prototype is centered on the C5ISR Modular Open Suite of S

Visa Accelerates Stablecoin Momentum: Adding Five Blockchains for Settlement29.4.2026 14:00:00 EEST | Press release

Today, Visa (NYSE: V) announced that it is adding five blockchains to its global stablecoin settlement pilot, expanding how issuers and acquirers can settle with the network. As stablecoins move into mainstream payment flows, Visa’s stablecoin settlement pilot now supports nine blockchains and has reached a $7 billion annualized stablecoin settlement run rate, up 50% since last quarter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429143049/en/ Visa is adding support for five additional blockchains, further expanding its multi-chain settlement capabilities. “Our partners are building in a multi-chain world, and they expect their options to reflect that reality,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Expanding our stablecoin settlement pilot program to more blockchains means our partners can choose the networks that best fit their needs, while relying on Visa to provide

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indication. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors, BeOne Medicines, said: “HERIZON‑GEA‑01 has the potential to shift the treatment paradigm in this historically difficult-to-treat disease, with the TEVIMBRA-containing arm demonstrating an unprecedented 26-month survival benefit. The FDA’s Prior

European Commission (EC) Approves Henlius and Organon’s POHERDY ® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 12:30:00 EEST | Press release

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye